AB Science announced today that results from masitinib study AB12003 in prostate cancer have been presented at the 2021 American Urological Association

Ads

You May Also Like

MPI: Orphan Drug designation on Oncology Venture’s dovitinib for Adenoid Cystic Carcinoma

Hoersholm, Denmark, June 28, 2018 -Medical Prognosis Institute A/S (MPI:ST) and Oncology Venture AB ...

Inspyr Therapeutics Announces Research Collaboration with the National Institutes of Health

WESTLAKE VILLAGE, Calif., Oct. 23, 2017 (GLOBE NEWSWIRE) -- Inspyr Therapeutics (OTCQB:NSPX), a clinical-stage ...